RASSF2
From Wikipedia, the free encyclopedia
Ras association (RalGDS/AF-6) domain family 2
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | RASSF2; DKFZp781O1747; KIAA0168 | |||||||||||||
External IDs | OMIM: 609492 MGI: 2442060 HomoloGene: 22840 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 9770 | 215653 | ||||||||||||
Ensembl | ENSG00000101265 | ENSMUSG00000027339 | ||||||||||||
Uniprot | P50749 | Q8BMS9 | ||||||||||||
Refseq | NM_014737 (mRNA) NP_055552 (protein) |
NM_175445 (mRNA) NP_780654 (protein) |
||||||||||||
Location | Chr 20: 4.71 - 4.75 Mb | Chr 2: 131.68 - 131.72 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Ras association (RalGDS/AF-6) domain family 2, also known as RASSF2, is a human gene.[1]
This gene encodes a protein that contains a Ras association domain. Similar to its cattle and sheep counterparts, this gene is located near the prion gene. Two alternatively spliced transcripts encoding the same isoform have been reported.[1]
[edit] References
[edit] Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298.
- Nagase T, Seki N, Ishikawa K, et al. (1996). "Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1.". DNA Res. 3 (1): 17–24. PMID 8724849.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149.
- Comincini S, Castiglioni BM, Foti GM, et al. (2001). "Isolation and molecular characterization of rasfadin, a novel gene in the vicinity of the bovine prion gene.". Mamm. Genome 12 (2): 150–6. PMID 11210185.
- Deloukas P, Matthews LH, Ashurst J, et al. (2002). "The DNA sequence and comparative analysis of human chromosome 20.". Nature 414 (6866): 865–71. doi: . PMID 11780052.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Vos MD, Ellis CA, Elam C, et al. (2003). "RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor.". J. Biol. Chem. 278 (30): 28045–51. doi: . PMID 12732644.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Fujita H, Fukuhara S, Sakurai A, et al. (2005). "Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes.". J. Biol. Chem. 280 (6): 5022–31. doi: . PMID 15569673.
- Hesson LB, Wilson R, Morton D, et al. (2005). "CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.". Oncogene 24 (24): 3987–94. doi: . PMID 15806169.
- Akino K, Toyota M, Suzuki H, et al. (2005). "The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.". Gastroenterology 129 (1): 156–69. PMID 16012945.
- Endoh M, Tamura G, Honda T, et al. (2006). "RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer.". Br. J. Cancer 93 (12): 1395–9. doi: . PMID 16265349.
- Zhang Z, Sun D, Van do N, et al. (2007). "Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.". Int. J. Cancer 120 (1): 32–8. doi: . PMID 17013896.
- Park HW, Kang HC, Kim IJ, et al. (2007). "Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.". Int. J. Cancer 120 (1): 7–12. doi: . PMID 17013898.
- Kumari G, Singhal PK, Rao MR, Mahalingam S (2007). "Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals.". J. Mol. Biol. 367 (5): 1294–311. doi: . PMID 17320110.
- Kaira K, Sunaga N, Tomizawa Y, et al. (2007). "Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.". Int. J. Oncol. 31 (1): 169–73. PMID 17549418.